This website uses technical, customisation and analytical cookies, both first-party and third-party, to anonymously facilitate browsing and analyse statistics on use of the website. Learn more
Search results
-
Gillette Company (E): Procter & Gamble
Kanter, Rosabeth Moss; Bird, MatthewCase HBS-309033-EAfter arriving in 2001 as the first outsider Chairman and CEO in Gillette history, Jim Kilts had led a remarkable turnaround. But by late 2004 he had to make a difficult decision. To better position the 104-year-old, Boston-based company, he opted to sell it to Cincinnati-based Procter & Gamble. How should Kilts lead the transition?Starting at €5.74
-
Piramal e-Swasthya (B): Considering Change, Teaching Note
Kanter, Rosabeth Moss; Kim, Joyce J.Teaching Note HBS-320013-ETeaching note for case 320011.Starting at €0.00
-
Gillette Company (A), (B), (C), (D), and (E), Teaching Note
Kanter, Rosabeth Moss; Bird, MatthewTeaching Note HBS-312114-ELeadership and People ManagementTeaching Note for 303032, 303033, 303034, 303035, 309033.Starting at €0.00
-
Piramal e-Swasthya (A): Attempting Big Changes for Small Places - in India and Beyond
Kanter, Rosabeth Moss; Bird, MatthewCase HBS-310134-EKnowledge and CommunicationAnand Piramal and his team sought to "democratize healthcare" in India through the development of a new service delivery model. If Henry Ford could build and deliver cars to everyone in the United States, Piramal thought, then why can't India deliver healStarting at €8.20
-
Piramal e-Swasthya (C): A New Name, Bigger Scope, and Public-Private Partnerships, Teaching Note
Kanter, Rosabeth Moss; Kim, Joyce J.Teaching Note HBS-320014-EEntrepreneurshipTeaching note for case 320012.Starting at €0.00
-
Piramal e-Swasthya (A): Attempting Big Changes for Small Places - in India and Beyond, Teaching Note
Kanter, Rosabeth Moss; Bird, MatthewTeaching Note HBS-311132-ETeaching Note for 311132.Starting at €0.00
-
Reinventing Brainlab
Herzlinger, Regina E.; Dessain, Vincent; Misztal, KarolCase HBS-313069-EStrategyThe management of Germany's Brainlab AG, a leading provider of software-driven oncology and surgery solutions, needs to evaluate strategic options for proceeding without an exclusive hardware partner in its most profitable business segment.Starting at €8.20
-
Sanofi Pasteur: The Dengue Vaccine Dilemma
Rangan, V. Kasturi; Bloom, David E.; Dessain, Vincent; Billaud, EmilieCase HBS-514074-EIn 2012, Sanofi Pasteur was racing to develop a vaccine against dengue, a mosquito-borne disease, and was evaluating this product in a Phase IIb trial conducted with school children in Thailand. But while the candidate vaccine met the high safety expectations and a good balanced immune answer, it had a proof of efficacy of only 30%, far below the 70% mark the company had targeted. Guillaume Leroy, vice president of the Dengue Company at Sanofi Pa...Starting at €8.20
-
Roche's Acquisition of Genentech
Baldwin, Carliss Y.; Becker, Bo; Dessain, VincentCase HBS-210040-EFinanceFranz Humer, CEO of the Roche Group, must decide whether to mount a hostile tender offer for the publicly-owned shares of Roche's biotechnology subsidiary, Genentech. The case provides opportunities to analyze Roche's strategy with respect to Genentech, tStarting at €8.20
-
Uber and Stakeholders: Managing a New Way of Riding
Kanter, Rosabeth Moss; Fox, DanielCase HBS-315139-EKnowledge and CommunicationBy 2015, technological innovations-the smartphone and the advanced data connectivity that enabled it-created new opportunities for people to move around cities quickly and conveniently without owning a car, via car-sharing services like Zipcar or new rideStarting at €8.20